Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rangering i aksjer #31187
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aksjekurs
$0.03808538
Markedsverdi
$14.04M
Endring (1 dag)
-3.57%
Endring (1 år)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Kategori

EPS for BCAL Diagnostics Limited (BDX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til BCAL Diagnostics Limited er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for BCAL Diagnostics Limited fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter